Although the pHR between hG-III CDKN2A/B -HD and hG-IV CDKN2A/B -HD did not reach statistical significance ( P = .24), the RMST between them showed a difference by 9.5 months at 60 months ( P = .03) ( Figure 4D ).
← all excerpts
Prognostic implication of <i>CDKN2A/B</i> homozygous deletion on histological grades in isocitrate dehydrogenase-mutant astrocytomas: A systematic review and meta-analysis.
1
0.2400
0.2400